MENU
VTGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

VistaGen Therapeutics (VTGN) Ownership - Who owns VistaGen Therapeutics?

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
41
Web
https://www.vistagen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.09M
P/E Ratio
N/A
Total Cash
31.73M
Projected Growth
N/A
Total Debt
783K
Revenue
2.5M
Risk (Beta)
1.64
Dividend Yield
N/A
Total Cash/Share
0.72
Total Debt/Equity
N/A
Revenue/Share
0.06 USD as % of share price
View a ticker or compare two or three
VTGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology

Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
41
Web
https://www.vistagen.com
Who owns VistaGen Therapeutics? VTGN symbol Ownership - Tickeron.com